J Patel

Potential treatment-cost savings from stage-shift in head and neck cancer in England

BACKGROUND: Head and neck cancer (HNC) poses a significant and growing economic burden on the NHS. Treatment costs are higher for late-stage disease, yet most patients in England present at advanced stages. Population-level screening may shift stage distribution at diagnosis, but...